PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-14.95%
Both yoy net incomes decline, with AVGO at -12.12%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-4.60%
Both reduce yoy D&A, with AVGO at -2.40%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-52.94%
Negative yoy deferred tax while AVGO stands at 95.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
24.14%
SBC growth while AVGO is negative at -9.52%. John Neff would see competitor possibly controlling share issuance more tightly.
-206.15%
Both reduce yoy usage, with AVGO at -968.42%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-131.45%
AR is negative yoy while AVGO is 80.38%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-242.50%
Negative yoy inventory while AVGO is 3500.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-5300.00%
Both negative yoy AP, with AVGO at -183.95%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-479.49%
Both reduce yoy usage, with AVGO at -216.36%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
129.30%
Some yoy increase while AVGO is negative at -63.16%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-54.34%
Both yoy CFO lines are negative, with AVGO at -18.56%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
24.39%
Some CapEx rise while AVGO is negative at -32.08%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
81.02%
Purchases well above AVGO's 80.00%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
105.95%
Liquidation growth of 105.95% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
94.83%
Growth well above AVGO's 17.02%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
184.89%
We have mild expansions while AVGO is negative at -32.81%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment above 1.5x AVGO's 8.33%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
-38.18%
Negative yoy issuance while AVGO is 30.91%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-0.48%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.